Senseonics keeps busy with Europe launch, Roche partnerships while FDA wait continues

As implantable CGM company Senseonics continues to wait for clearance from the FDA, the company isn ' t sitting on its hands. On a Q2 earnings call, CEO Tim Goodnow reported that the company continues to expand its operations in Europe, is close to a CE Mark for a longer-lasting second generation device, and is partnering with Roche and Type Zero on an artificial pancreas study with an eye on commercialization.
Source: mobihealthnews - Category: Information Technology Source Type: news